Active, not recruitingPhase 2NCT05953389

Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents

Studying Interatrial communication

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bioprojet
Principal Investigator
Olivier Bonnot, MD, Prof.
Etablissement Public de Santé Barthélemy Durand, Sainte-Geneviève-des-Bois, France
Intervention
Pitolisant(drug)
Enrollment
62 target
Eligibility
6-17 years · MALE
Timeline
20232025

Study locations (15)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05953389 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication

← Back to all trials